Home / About us / Our team

Global teams working in sync

Close, collaborative and committed to your program from day one, our transatlantic teams adapt quickly to keep your science and programs on track.

Leadership

Guillaume Jetten, Drs., RA

Chief Executive Officer (CEO)

Gabriella Gentile, Ph.D. MBA

Chief Operating Officer (COO)

Philip Payne

Chief Commercial Officer (CCO)

Outi Kontkanen, Ph.D.

CEO, Admescope

Kees Groen, Ph.D.

Co-founder and CEO, Dgr Pharma

Paul O’Shea

Founder and CEO, Exemplify Biopharma

Anu Mahadevan

CEO, Organix

Yadan Chen

Managing Director, Exemplify Biopharma

Jorg Benningshof

Head of Scientific Operations

Paul Blundell, Ph.D.

President, Organix

Melloney Dröge, PharmD, Ph.D.

Managing Director, Drug Discovery

Titia Mulders, Ph.D.

Managing Director, Drug Development

Martin Caine

Head of HR, Global

Our global presence, your strategic advantage

With sites across Europe and North America, we offer proximity, flexibility and seamless transatlantic collaboration. We eliminate barriers and align disciplines across regions to keep your science moving. Wherever you are, our connected teams deliver local insight and global expertise.

Quality and confidence in whatever comes next

When so much is at stake, you need unwavering quality, clear thinking and seamless continuity across disciplines and milestones — so you can move forward with confidence. We combine scientific precision, proven processes and cross-functional insight to reduce risk and accelerate your progress from inception to IND.

Connect with our discovery and development experts

Ready to move forward?

Contact us to discuss how we can support the discovery and development of your next breakthrough.